Trinidad-and-Tabago-Congerss-Abstract-Book

More documents

Recommendations

Info

20 th ISRRT World Congress 2018 Hosted by Website: www.isrrt2018.org.tt Email: queries@isrrt2018.org.tt Professionalism in Radiation Therapy: What Should It Look Like? RT1-4 Kristin Berry, Marcia Smoke MSc, MRT(T), RTT, ACT, Emily Ho BMRSc, MRT(T), RT(T), Salman Arif BHSc, BMRSc, MRT(T) & Joseph E. Hayward PhD, MCCPM Juravinski Cancer Centre, McMaster University & Mohawk College Medical Radiation Sciences Program, Canada Purpose: The aim of this study was to compare perceptions of professionalism among radiation therapists and patients at a large, academic, Canadian Cancer Centre. The study included patients undergoing radical radiation treatment as well as radiation therapists with differing levels of experience. Methods: A quantitative survey was developed after conducting a comprehensive literature review. Using a five-point Likert scale, participants were asked to rate the importance of 22 traits and behaviours as they relate to the professionalism of a radiation therapist. Participants were also asked to indicate which behaviours they felt were most important and which were least important. Participation was on a volunteer basis with 28 radiation therapists and 73 patient participants. Data were analyzed using the Mann-Whitney and Kruskal-Wallis tests with a significance level α=0.05 to determine if there were any significant differences in the median responses between the two participant groups as well as among varying demographic traits. Results: The results indicated that as compared to radiation therapists, patients attributed a higher level of importance to traits surrounding empathy and compassion, communication, positive work atmosphere and confidentiality. Both radiation therapists and patients agreed that competence was the most important behaviour and that appearance of the radiation therapist was the least important trait to professionalism. There were no significant differences among varying demographics except for patient gender. Female patients valued behaviours related to communication and respect for authority more than male patients. Conclusion: This study suggests that for quality patient care, professionalism policies should place more emphasis on radiation therapist competency and should include communication traits. Future research could benefit from a qualitative approach to gather the unique perspective of patients and radiation therapists allowing for thematic analysis. Qualitative research could address why there is a difference between patients’ and radiation therapists’ perceptions of professionalism. The Alberta, Canada Ocular Brachytherapy Program. Utilizing Patient Feedback to Guide Improvement RT1-5 Wendy Read MRT(T), ACT, FCAMRT 1 ; R. Trafford Crump Ph.D.; Ezekiel Weis MD, MPH, FRCSC, Diplomate ABO 1 Brachytherapist, Cross Cancer Institute Edmonton, Canada Purpose: Uveal melanoma is the most common primary adult ocular tumor (iris, ciliary body and choroid). It accounts for just 5% of all melanomas. Patients face a poor prognosis, with a serious threat of visual loss and the consequences associated with that impaired function.Historically, treatment was by enucleation, providing a histological diagnosis and effective tumor treatment. These benefits however, were obtained at the cost of immediate complete visual loss. In an effort to preserve both vision and globe, episcleral plaque brachytherapy has become an effective treatment alternative.The objective of this project was to measure, evaluate, and report on the care experiences of patients who were treated at the Alberta Ocular Brachytherapy Program. A knowledge gap currently exists with patient experience and satisfaction during treatment. By objectively measuring these experiences, the clinical team can improve their delivery of patient-centered care. Methods: The validated Consumer Assessment for Healthcare Providers and Systems (CAHPS) Adult Surgical Survey was modified to include questions assessing brachytherapy care. Patients were chosen from the program's clinical database. Two mail outs were sent 4-15 months post-surgery. Data was collected using the RedCap (Research electronic data Capture) website. Results: 25 surveys were used for analysis. Response rate 62.5%. Overall patients were satisfied with the quality of care. Ratings were lowest for: communication regarding the post-operative course while the plaque was in place and post-operative pain management. Functioning ability during treatment was explored. Vision was affected in 52% of respondents, mood-28%, sleep-36%, driving ability-62.5%, reading ability-60% and ability to perform daily care-20.8%. 20 th International Society of Radiographers and Radiological Technologist, World Congress April 12 – 15, 2018 • Hyatt Regency Trinidad, Wrightson Road, Port of Spain, Trinidad, W.I. Website: www.isrrt2018.org.tt Email: queries@isrrt2018.org.tt
20 th ISRRT World Congress 2018 Hosted by Website: www.isrrt2018.org.tt Email: queries@isrrt2018.org.tt Conclusion: The survey showed that overall patients were satisfied with the care they received. The responses highlighted two areas for improvement: communication regarding the post-operative course while the plaque is in place and post-operative pain management. MRI Eight Year Interim Results of a 20- Year Observational Study of Transrectally Delivered, MRI-Guided Laser Interstitial Thermal Therapy of Prostate Cancer in an Outpatient Setting Bernadette M. Greenwood 1 , John F. Feller, MD, Wes Jones, RT 1 Chief Research Officer, Desert Medical Imaging, USA MRI1-1 Purpose: In the United States alone, new prostate cancer cases for 2016 were estimated at 180,890 and deaths at 26,1201. Focal therapies for low risk and intermediate risk localized prostate cancer are increasingly being explored. Additionally, new treatments for patients in a salvage setting are being studied. Our objective is to investigate the efficacy of using MR-guided laser focal therapy for MR visible prostate cancer utilizing a transrectal approach for laser applicator placement and therapy delivery in an outpatient setting. Lasers have been used for soft tissue necrotization for decades2. A commercially available MR-guided biopsy system accommodates insertion of a 980nm laser fiber for insertion into biopsy proven cancerous lesions facilitating ablation of MR-visible tumor. Methods: All MRI-guided therapy was delivered using a 1.5 Tesla Philips Achieva XR system (Philips Healthcare, Best, The Netherlands) for both image acquisition and real-time thermometry. DynaCAD and DynaLOC (Invivo, Orlando, FL, USA) software were used for image analysis and laser fiber placementl planning. Laser focal therapy was delivered using a Visualase (Medtronic, Minneapolis, MN, USA) 15W, 980 nm diode laser applicator introduced transrectally using the DynaTRIM (Invivo, Orlando, FL, USA). MR imaging was used to monitor energy deposition and coagulation necrosis. Results: Under IRB-approved, HIPAA-compliant protocol, 98 men were treated. 138 cancer foci were treated. Total procedure time was between 1.5 and four hours MRI volume of coagulation necrosis ranged from 0.6 to 38 cc (average 7.7cc). No serious adverse events or morbidity were reported. Of the 30 positive 6 mo. Biopsies, 23 were of the treatment regions, consistent with residual or recurrent cancer in 23% of biopsies performed of the treatment site at 6 mos. post therapy. We observed a 45% decrease in mean PSA at 12 months post therapy and no statistically significant change in IPSS and SHIM scores. Conclusion: Our data indicate that outpatient, transrectally delivered MRI-guided laser focal therapy for prostate cancer is both safe and feasible. In the current climate of cost-reduction and emphasis on minimally-invasive treatment of cancer, focal treatment of prostate cancer may be an attractive option. The precision and controllability achieved under MRI-guidance may have favourable results for cost effectiveness and quality of life without eliminating the possibility of whole-gland treatment in the patient’s future. We will continue to follow these men for twenty years as part of an IRB-approved clinical trial (NCT# 02243033)3. Genomics Bernadette M. Greenwood 1 1 Chief Research Officer, Desert Medical Imaging, USA MRI1-2 Axumin Bernadette M. Greenwood 1 1 Chief Research Officer, Desert Medical Imaging, USA MRI1-3 20 th International Society of Radiographers and Radiological Technologist, World Congress April 12 – 15, 2018 • Hyatt Regency Trinidad, Wrightson Road, Port of Spain, Trinidad, W.I. Website: www.isrrt2018.org.tt Email: queries@isrrt2018.org.tt
Page 1 and 2: 20 th ISRRT World Congress 2018 Hos
Page 29: 20 th ISRRT World Congress 2018 Hos
Page 81 and 82:
20 th ISRRT World Congress 2018 Hos
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
show all

Trinidad-and-Tabago-Congerss-Abstract-Book

Create successful ePaper yourself

Delete template?

Save as template?